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Short running title: 
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Introduction 
Many studies over the past two decades have investigated hepatotropic factors that could 
prevent hepatic failure after extended hepatectomy or other types of liver damage1, 2.  
However, such factors have not proven clinically applicable.  Platelets have thrombotic effects 
and also play important roles in wound healing and tissue regeneration3-6.  We recently 
reported that platelets play a very important role in liver regeneration after extended 
hepatectomy7-9.  Furthermore, a low platelet count in humans is associated with delayed 
recovery of liver function after partial liver resection10.  Platelets contain many growth factors, 
such as PDGF, HGF, VEGF, EGF, and TGF-β11-16, that are required for tissue regeneration3, 4, 17, 
and we reported that growth factors in platelets, such as HGF, and IGF-1, are critical for 
hepatocyte proliferation8.  We showed that endogenous platelets accumulate in the livers of 
mice immediately after 70% hepatectomy and that platelets migrate from sinusoidal spaces into 
Disse’s spaces through the fenestration of sinusoidal endothelial cells7.  We also reported that 
platelets accumulate in the rat liver after 70% hepatectomy and that residual liver regenerates 
sooner in such rats7.  Endogenous platelets accumulate in the damaged liver and actively 
translocate into Disse’s spaces in response to lipopolysaccharides7, 18-23.  These findings 
indicated that platelet accumulation would provide a natural delivery system of growth factors 
and that platelets could prevent hepatic failure due to hepatocyte apoptosis.  We therefore 
speculated that platelets could promote liver regeneration after massive hepatectomy. 
Here, we postulated that exogenous platelets infused via the portal vein could promote 
liver regeneration and investigated the clinical applicability of platelet therapy for liver 
regeneration by infusing platelet-rich plasma via the portal vein after 70% hepatectomy and 
evaluated residual liver regeneration in rats.  To clarify the mechanisms through which 
platelets promote liver regeneration, we also investigated the STAT3, Akt, and ERK1/2 
signaling pathways.  We also analyzed the dynamics of platelets infused via the portal vein 
before and after 70% hepatectomy in rats. 
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Methods 
 
Animals 
Seven-week-old male SD rats (Clea, Tokyo, Japan), weighing 180 to 200 g each were 
housed (4 per cage) in an animal room under a 12-h light/12-h dark cycle with free access to 
water and standard chow.  All animal experiments proceeded in a humane manner after 
receiving approval from the Institutional Animal Experiment Committee of the University of 
Tsukuba.  These experiments also proceeded in accordance with the Regulations for Animal 
Experiments at our institution and with the Fundamental Guidelines for the Proper Conduct of 
Animal Experiment and Related Activities in Academic Research Institutions under the 
jurisdiction of the Ministry of Education, Culture, Sports, Science and Technology of Japan. 
 
Preparation of washed platelets 
Blood was obtained from rats via the inferior vena cava under ether anesthesia.  
Platelet-rich plasma (PRP) was obtained by centrifuging anticoagulated blood in acid citrate 
dextrose (ACD) in a 1:4 volume ratio at 200 × g and 24°C for 10 min.  The platelets were 
then washed twice by centrifugation at 1000 × g and 4°C for 15 min, resuspended in citrate 
buffer (120 mM NaCl, 4.26 mM NaHPO4, 5.5 mM glucose, 4.77 mM sodium citrate, and 2.35 
mM citric acid), adjusted to pH 6.5 and suspended in normal saline at a density of 1 × 109/mL. 
 
Labeling platelets with rhodamine 6G 
Platelets were isolated from the whole blood of syngenic rats and labeled with 
rhodamine-6G (0.05%; 50 μL/mL whole blood: R-4127; Sigma, St. Louis, MO, USA), as 
described22, 24.  Briefly, blood was mixed with prostaglandin E1 and rhodamine-6G and 
diluted with buffer.  After two cycles of centrifugation, fluorescent platelets were resuspended 
in PBS. A total of 1 × 108 fluorescence-labeled platelets, representing about 1% of all 
circulating platelets in recipient rats, were injected via the portal vein before and after 70% 
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hepatectomy. 
 
Surgical procedure for 70% hepatectomy and PRP infusion 
Rats underwent 70% hepatectomy as described25.  Briefly, the left lateral, left median 
and right median liver lobes were surgically removed after laparotomy.  Thereafter, the cecal 
vein was punctured using a 20-G needle and an elastic catheter was inserted into the portal vein.   
The rats were assigned to groups that were infused via the portal vein over a period of 1 min 
immediately after hepatectomy with 1 mL of either normal saline (NS group) or platelet-rich 
plasma (PRP group).  The amount of platelets corresponded to 10% of the total circulating 
platelets in each rat.  All surgical procedures were performed under ether anesthesia as 
approved by our institutional review board.  The rats were sacrificed and liver specimens 
were collected at 24 h after surgery to assess liver regeneration and at 15, 30, 60, 120 and 240 
min after surgery to analyze signal transduction.  Blood samples were collected at 24 h after 
surgery to assess liver damage. 
 
Plasma assays 
Serum from blood samples collected at 24 h after hepatectomy was obtained by 
centrifugation at 3000 rpm for 10 min, and stored at -70°C.  Serum levels of AST, ALT, LDH, 
ALP and total-bilirubin were measured in both groups. 
 
Histological and immunohistological analysis 
Liver specimens were fixed for histological analysis in 10% neutral-buffered formalin, 
embedded in paraffin, sliced into 4-µm sections and stained with hematoxylin-eosin.  Ki-67 
was immunohistochemically stained according to the manufacturer’s guidelines.  Briefly, liver 
specimens were embedded in Optimal Cutting T (OCT) compound (Tissue-Tek; Sakura Fine 
Technical, Tokyo, Japan) and then frozen sections (10 µm) were fixed in 10% formalin for 1 
min.  Endogenous peroxidase was inactivated by immersion in 0.3% hydrogen peroxide in 
absolute methanol for 5 min, and then the sections were washed with PBS.  The sections were 
incubated with 3% bovine serum albumin for 30 min, followed by Ki-67 antibody (YLEM, 
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Rome, Italy) at room temperature for 60 min.  Primary antibody reactions were enhanced 
using horseradish peroxidase (HRP)-conjugated antibody, EnVision (Dako, Carpinteria, CA, 
USA) and immunoreactivity was visualized using 0.05% 3,3-diaminobenzidine (DAB).  
Specimens were washed in distilled water, counterstained with hematoxylin for 2 min and then 
mounted.  The Ki-67 labeling indices of hepatocytes were determined from random 
evaluations of over 2000 hepatocytes and are expressed as ratios (%). 
 
Western blotting  
Samples were boiled in 125 mM Tris-HCL buffer (pH 6.8), containing 5% glycerol, 2% 
sodium dodecyl sulfate (SDS) and 1% 2-mercaptoethanol for 5 min, resolved by 10% 
SDS-PAGE and then transferred to nitrocellulose membranes.  Samples were blotted against 
phospho-STAT3, phospho-Akt, phospho-ERK1/2, and β-actin primary antibodies (Cell 
Signaling, Beverly, MA, USA). 
 
Platelet dynamics 
We analyzed the dynamics of infused platelets before and after hepatectomy by intravital 
fluorescence microscopy using a modified microscope (BX30 FKA-SP; Olympus, Tokyo, 
Japan) with a 100-W mercury lamp attached to a filter block.  Hepatic microcirculation was 
recorded using a charge-coupled device (CCD) camera (C5810 NTSC; Sony, Tokyo, Japan) for 
offline evaluation.  Magnification of 325× to 650× was achieved on the video screen using 
water-immersion objective lenses (W10 ×/0.3 to W20 ×/0.7; Olympus, Tokyo, Japan).  
Microcirculatory platelet-endothelial cell interactions were analyzed using videotaped images.  
Rhodamine-6G labeled platelets were infused via the portal vein before or after hepatectomy, 
and 7-10 randomly selected acini were visualized as described22. 
 
Statistical analysis 
Results are expressed as means ± S.D.  Data were statistically analyzed using 
Student’s t test.  Values of p < 0.05 were considered statistically significant for all findings. 
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Results 
Platelet counts 
We counted platelets in the peripheral blood before and after platelet infusion via the 
portal vein to determine their effects on the blood circulation.  The counts did not 
significantly differ before and after platelet infusion (data not shown). 
 
Liver regeneration 
We measured the ratios of residual liver to body weight at 24 h after 70% hepatectomy 
(partial hepatectomy, PH) to determine the effect of platelet infusion on liver mass recovery 
(Fig. 1). Each group comprised 9 rats.  The liver/body weight ratio at 24 h after PH was 
significantly higher in the PRP, than in the NS group (p < 0.05). 
 
Histological analysis 
Light microscopy of liver tissues at 1, 24 and 48 hours after portal infusion did not 
uncover any serious changes (data not shown). 
 
Immunohistochemical staining of Ki-67 
We evaluated hepatocyte proliferation by immunohistochemically staining liver 
specimens for Ki-67.  Each group comprised 6 rats. The Ki-67 labeling index was 
significantly higher in the PRP, than in the NS group as shown in Figures 2 and 3 (p < 0.05). 
 
Cellular signal transduction 
We examined the activation of Akt, ERK1/2, and STAT3 signal transduction to 
understand the effect of PRP infusion on cellular signaling pathways of the regenerating liver.  
These factors are closely associated with liver regeneration.  The data in Figure 4 shows that 
Akt was phosphorylated earlier in the PRP, than in the NS group, and that although ERK1/2 
was simultaneously phosphorylated in both groups, it persisted after PH in the PRP group.  
The phosphorylation of STAT3 did not apparently differ between the two groups (Fig. 4). 
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Platelet accumulation after hepatectomy visualized using CCD camera 
Significantly more platelets adhered after, than before hepatectomy in the PRP group 
(Fig. 5). 
 
Plasma liver function 
We assayed plasma liver function in rats infused with PRP or NS for 24 h after 
hepatectomy to determine liver injury due to PRP infusion via the portal vein.  Each group 
comprised 10 rats.  The data in Table 1 shows that liver function did not significantly differ 
between the two groups (p < 0.05). 
 
 
Discussion 
Platelets are activated at the site of injury to intensify the coagulation process6.  We 
previously reported that thrombocytosis promotes liver regeneration after partial hepatectomy21, 
23 and HGF and IGF-1 are essential for hepatocyte proliferation9.  Thrombopoietin or 
splenectomy are often used to increase platelet counts both experimentally and clinically.  
However, the effect of thrombopoietin lasts for a specific period and that of splenectomy is 
essentially permanent.  This might cause thrombocytosis and various organs to become 
dysfunctional.  We postulated that a local and single administration of platelets during the 
critical period for liver regeneration would help to resolve these issues.  We examined the 
maximal dose of platelets that could be safely infused via the portal vein without causing 
thrombosis and liver dysfunction in preliminary study. We confirmed that infusing 10% of the 
total amount of platelets did not cause either thrombosis or liver damage.  In addition, we 
examined the critical timing for platelet administration by visualizing platelet dynamics before 
and after hepatectomy using intravital fluorescence microscopy. We confirmed that platelets 
infused via the portal vein accumulated in the sinusoids immediately after hepatectomy and 
speculated that platelet infusion could be applicable as liver regeneration therapy. The present 
findings indicated that a single administration of platelets via the portal vein obviously 
promoted liver regeneration after 70% hepatectomy. 
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We assessed liver regeneration by comparing liver/body weight ratios at 24 h after 
hepatectomy and measured the Ki-67 labeling index as an indicator of cell proliferation in the 
PRP and NS groups. Both values were significantly higher in the PRP, than in the NS group.  
These results indicated that the administration of platelets induces prompt signal transduction 
for the proliferation of residual liver regeneration after massive hepatectomy. 
The Akt and ERK1/2 pathways are important signaling processes that are activated in 
the liver by platelets7, 8. Hepatocytes cultured with platelets immediately activate both the Akt 
and ERK1/2 pathways and hepatocytes start to proliferate8.  Inhibitors of PI-3K such as 
LY-294002 inhibit the proliferative effect of platelets on hepatocytes8.  The present study 
found that the Akt pathway was activated earlier in the PRP, than in the NS group and that 
ERK1/2 pathway activation persisted in the PRP, compared with the NS group.  These results 
support our previous findings that both the Akt and ERK1/2 pathways essentially contribute to 
liver regeneration.  On the other hand, STAT-3 was activated at the same time in each group 
and more STAT-3 was expressed in the controls.  The liver is a key vital organ in which the 
mechanisms of regeneration are highly orchestrated.  Many processes play roles in the total 
number of mechanisms that function during liver regeneration. Platelets comprise one 
important factor involved in liver regeneration7, 8,  and other mechanisms such as the Il-6 to 
STAT-3 pathway and substrates released from Kupffer cells as well as sinusoidal endothelial 
cells also play very important roles in liver regeneration26, 27.  These facts suggest that 
mechanisms via STAT-3 pathway compensated in the NS group for other mechanisms involved 
in platelet signaling. 
Only a few reports have described the movement of platelets in vivo28, 29.  Platelets 
accumulate in the liver in response to ischemic reperfusion22.  We investigated the dynamics 
of rhodamine-6G labeled platelets before and after hepatectomy, using an intra-vital video 
microscopy system.  Platelets flowed faster and fewer of them rolled and aggregated in the 
sinusoidal endothelium before hepatectomy.  In contrast, many platelets accumulated in the 
sinusoid, the flow rate decreased, and the platelets rolled and aggregated in the sinusoid after 
massive hepatectomy (see Video, Supplemental Digital Content 1 and 2 which demonstrate 
the dynamics of infused platelets in the sinusoid before and after hepatectomy).  Although 
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the mechanisms of platelet accumulation remain unclear, the present results indicated that 
platelets actually accumulate at the sinusoid of the residual liver after hepatectomy. 
The safety of PRP infusion is critical in the clinical setting.  Portal injection of 
platelets would have a maximal effect on regeneration of the residual liver. However, 
thrombosis and liver damage arising during infusion due to the inherent nature of platelets are 
critical concerns. Therefore, we evaluated serum liver markers and histological findings to 
determine liver injury after PRP infusion.  The results did not indicate any increase in liver 
damage in the PRP group.  In addition, neither embolism nor necrosis of the residual liver was 
recognized in the PRP group (data not shown).  These findings indicated that PRP infusion 
promotes liver regeneration after massive hepatectomy without liver damage. 
This is the first report to describe the clinical applicability of PRP infusion for liver 
regeneration therapy.  We believe that platelet infusion could offer a novel therapeutic 
strategy for liver regeneration after extended hepatectomy, liver damage or after small grafts 
in liver transplantation in the near future. 
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Legends for illustrations 
Fig. 1.  Liver/body weight ratio. 
Liver regeneration at 24 h after 70% hepatectomy is significantly higher in PRP than NS 
(control) group.  Columns and bars represent means ± SD. *p < 0.05 versus NS group (n = 9 
per group). 
 
Fig. 2.  Immunohistochemistry for Ki-67. 
Immunohistochemical staining of Ki-67 of PRP (A) and NS (B) samples at 24 h after 70% 
hepatectomy.  Ki-67 is remarkably stained in PRP compared with NS (control) group. 
 
Fig. 3.  Ki-67 labeling index. 
Ki-67 labeling index is significantly higher in PRP than NS (control) group. Columns and bars 
represent means ± SD. *p < 0.05 vs. NS group (n = 6 per group). 
 
Fig. 4.  Cellular signals. 
Cellular signals were analyzed before and after portal infusions of PRP and normal saline.  A. 
Akt was more rapidly activated in PRP than NS group. B. Activation of ERK1/2 pathway 
persisted longer in PRP than in NS group.  C. STAT-3 pathway activation is similar in both 
groups.  D. Equalized loaded protein confirmed by amount of β-actin at any time point in 
each group. 
 
Fig. 5.  Intravital-videomicroscopy. 
Platelet dynamics were analyzed before and after hepatectomy in PRP group.  Rhodamine  
6G-labelled platelets were infused via portal vein before and after hepatectomy.  Intravital  
video microscopy shows fewer platelets in sinusoid before (A), than immediately after (B) 
hepatectomy. 
 
List of abbreviations: 
ERK, extra cellular signal- regulated protein kinase; STAT3, signal transducer and activator of 
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transcription factor kB. 
 
Legends for Supplemental Digital Contents 
Supplemental Digital Content 1. 
Platelets flowed faster and fewer of them rolled and aggregated in the sinusoidal endothelium 
before hepatectomy.   
 
Supplemental Digital Content 2. 
Many platelets accumulated in the sinusoid, the flow rate decreased, and the platelets rolled 
and aggregated in the sinusoid after massive hepatectomy. 
 
 
List of Supplemental Digital Contents 
Supplemental Digital Content 1.  Video that demonstrates the dynamics of infused platelets in 
the sinusoid before hepatectomy.  wmv 
Supplemental Digital Content 2.  Video that demonstrates the dynamics of infused platelets in 
the sinusoid after hepatectomy.  wmv 
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